Shire U.S., Inc. v. Blackburn
Petition for certiorari denied on October 2, 2023
Issue: Whether a state-law claim is preempted if it places a duty on a drug manufacturer to unilaterally change language approved by the Food and Drug Administration that appears in the highlights section of a drug label.
| Date | Proceedings and Orders (key to color coding) |
|---|
| Mar 21 2023 | Application (22A846) to extend the time to file a petition for a writ of certiorari from April 5, 2023 to May 5, 2023, submitted to Justice Thomas. |
| Mar 29 2023 | Application (22A846) granted by Justice Thomas extending the time to file until May 5, 2023. |
| Apr 18 2023 | Application (22A846) to extend further the time from May 5, 2023 to June 4, 2023, submitted to Justice Thomas. |
| Apr 25 2023 | Application (22A846) granted by Justice Thomas extending the time to file until June 4, 2023. |
| Jun 02 2023 | Petition for a writ of certiorari filed. (Response due July 7, 2023) |
| Jun 22 2023 | Motion to extend the time to file a response from July 7, 2023 to August 7, 2023, submitted to The Clerk. |
| Jun 23 2023 | Motion to extend the time to file a response is granted and the time is extended to and including August 7, 2023. |
| Jul 07 2023 | Amicus brief of Pharmaceutical Research Manufacturers of America not accepted for filing (duplicate electronic filing). (July 12, 2023) |
| Jul 07 2023 | Brief amicus curiae of Pharmaceutical Research Manufacturers of America filed. |
| Jul 12 2023 | Brief of respondent Mark Blackburn in opposition filed. |
| Jul 26 2023 | DISTRIBUTED for Conference of 9/26/2023. |
| Jul 26 2023 | Reply of petitioners Shire US Inc., et al. filed. (Distributed) |
| Oct 02 2023 | Petition DENIED. |
